Head-to-head · Cost-Efficiency Index
Coivas vs Human+
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Coivas
Shoppers wanting a named, verifiable prescribing physician (NPI-checkable) behind a nationwide compounded GLP-1 service.
Visit CoivasHuman+
Cost-first shoppers who want pharmacy-wholesale pricing via a flat membership, in any state.
Visit Human+The verdict
Coivas and Human+ tie on the Cost-Efficiency Index at 58/100, so neither wins outright on the numbers. For most shoppers we'd start with Coivas (ranked #284, a hair above #287) — Shoppers wanting a named, verifiable prescribing physician (NPI-checkable) behind a nationwide compounded GLP-1 service. But Human+ is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Coivas.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Coivas | Human+ |
|---|---|---|
| Cost-Efficiency Index | 58/100 | 58/100 |
| Semaglutide / mo | $119/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide / mo | $199/mo (starting dose, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,428 | — |
| Tirzepatide / yr (modeled) | $2,388 | — |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #284 | #287 |
Coivas
58/100Where the value is
- Named prescribing physician with checkable NPI (Dr. Sean Arora, NPI 1841729449)
- LegitScript approval seal displayed
- Claims availability in all 50 states
The tradeoffs
- 'Starting at' pricing could not be confirmed as the genuine ongoing rate -- pricing subpages were unreachable (404)
- No single named compounding pharmacy -- varies by location/medication
Human+
58/100Where the value is
- Cost-transparent model: a flat monthly membership with prescriptions billed at pharmacy-wholesale cost instead of marked up
- Available via telehealth in all 50 states
- Filled by US 503A compounding pharmacies and reviewed by board-certified US-licensed clinicians
The tradeoffs
- Specific GLP-1 medications and pricing are not published — you only see them after starting the intake
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.